SCHEDULE 13G/A
Statement of Beneficial Ownership
Maze Therapeutics, Inc. Filed Acc 0001193125-26-463548
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Third Rock Ventures IV, L.P. | 3,723,958 | 6.7% |
| Third Rock Ventures GP IV, L.P. | 3,723,958 | 6.7% |
| TRV GP IV, LLC | 3,723,958 | 6.7% |
| Third Rock Ventures V, L.P. | 950,800 | 1.7% |
| Third Rock Ventures GP V, L.P. | 950,800 | 1.7% |
| TRV GP V, LLC | 950,800 | 1.7% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Loading xslSCHEDULE_13G_X02/primary_doc.xml…